$BAX Income Statement | Understand Stock

$BAX

$24.92 -$0.37 (1.46%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net sales
Cost of sales
Gross margin
Selling, general and administrative expenses
Research and development expenses
Other operating expense (income), net
Operating income (loss)
Interest expense, net
Other (income) expense, net
Income (loss) from continuing operations before income taxes
Income tax (benefit) expense
Income (loss) from continuing operations
Income (loss) from discontinued operations, net of tax
Net income (loss)
Less: Net income attributable to noncontrolling interests included in discontinued operations
Less: Net income attributable to noncontrolling interests included in continuing operations
Less: Net income attributable to noncontrolling interest included in discontinued operations
Total less: Net income attributable to noncontrolling interests included in discontinued operations
Net income (loss) attributable to Baxter stockholders
Income (loss) from continuing operations per common share
Basic (in dollars per share)
Diluted (in dollars per share)
Income (loss) from discontinued operations per common share
Basic (in dollars per share)
Diluted (in dollars per share)
Net Income (loss) per common share
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average number of shares outstanding
Basic (in shares)
Diluted (in shares)

Comments